Evaluation of the Safety and Effectiveness of the Investigational Product in Improvement of the Appearance of Wrinkles and General Aspect of the Skin

Inclusion criteria

• Participants aged between 30 and 55 years old;
• Participants with all skin types (normal, dry, combination and oily);
• Participants with mild to moderate signs of aging, according to Lanier's classification;
• Participants with melanic and/or vascular dark circles;
• Participants with bags around their eyes;
• Users of products from the same category;
• Intact skin in the product analysis region (face);
• Participants who agree NOT to use any other topical products on the test area during the study period;
• Agreement to comply with the trial procedures and to attend the clinic on the specified days and times;
• Understand, consent and sign the informed consent.

Exclusion criteria

• Participants diagnosed with COVID-19 in the last 4 weeks or showing symptoms such as fever, dry cough, tiredness, body aches or other discomfort;
• Pregnancy/lactation or intention to become pregnant during the study period;
• Use of the following topical or systemic medications: immunosuppressants, antihistamines, non-steroidal anti-inflammatory drugs, and corticoids up to 30 days before selection or considering immunosuppressants, the interval should be 3 months before selection;
• Atopic or allergic history of health products;
• Pathologies and/or active skin lesions (local and/or disseminated) in the assessment area;
• Skin marks in the experimental area that interfere with the evaluation of possible skin reactions (vascular malformations, scars, increased hairiness, large amounts of nevus, sunburn);
• Immunosuppression by drugs or active diseases;
• Decompensated endocrinopathies;
• Participants with known congenital or acquired immunodeficiency;
• Relevant medical history or current evidence of alcohol or other drug abuse;
• Known history or suspected intolerance to products in the same category
• Intense sun exposure up to 15 days before the assessment;
• Aesthetic or dermatological treatment in the evaluation area up to 04 weeks before selection;
• Professionals directly involved in carrying out this study;
• Other conditions considered by the evaluating physician as reasonable for disqualification from participating in the study. If yes, it should be described in observation in the clinical record